Search Results - "Jensen, Kamilla E"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Development of a highly sensitive chemiluminescence immunoassay for quantification of aggrecanase-generated ARGS aggrecan fragments in serum by He, Yi, Jensen, Kamilla E., Siebuhr, Anne Sofie, Karsdal, Morten A., Larkin, Jonathan, Bay-Jensen, Anne C.

    Published in Osteoarthritis and cartilage open (01-06-2021)
    “…Cartilage degradation is a hallmark of osteoarthritis (OA). Aggrecan, a major proteoglycan of articular cartilage extracellular matrix (ECM), is degraded by…”
    Get full text
    Journal Article
  6. 6

    Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA by Pinto, Vera V, Ditlev, Sisse B, Jensen, Kamilla E, Resende, Mafalda, Dahlbäck, Madeleine, Andersen, Gorm, Andersen, Pernille, Theander, Thor G, Salanti, Ali, Nielsen, Morten A

    Published in PloS one (25-03-2011)
    “…In Plasmodium falciparum malaria endemic areas placental malaria (PM) is an important complication of malaria. The recurrence of malaria in primigravidae women…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma by Rasmussen, Rikke D., Gajjar, Madhavsai K., Jensen, Kamilla E., Hamerlik, Petra

    Published in Molecular oncology (01-05-2016)
    “…Recent clinical trials have demonstrated that targeting chromatin remodeling factors is as a promising strategy for the treatment of glioblastoma (GBM). We and…”
    Get full text
    Journal Article
  10. 10

    CSIG-05. THE HISTONE CHAPERONE Spt6 IS REQUIRED FOR GENOMIC STABILITY OF GLIOBLASTOMA CANCER STEM-LIKE CELLS by Rasmussen, Rikke, Obara, Elisabeth A, Vitting-Serup, Kristoffer, Jensen, Kamilla E, Skjøth-Rasmussen, Jane, Brennum, Jannick, Bartek, Jiri, Hamerlik, Petra

    Published in Neuro-oncology (Charlottesville, Va.) (06-11-2017)
    “…Rampant genomic instability is a hallmark of glioblastoma (GBM). Despite recent advances in our understanding of this deadly disease, molecular mechanism…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    CB-05THE ROLE OF Emb-5 IN GLIOBLASTOMA MAINTENANCE AND THERAPEUTIC RESISTANCE by Rasmussen, Rikke D., Jensen, Kamilla E., Gajjar, Madhavsai K., Julie la Cour Karottki, Karen, Bartek, Jiri, Skjøth-Rasmussen, Jane, Tluckova, Lucie, Hamerlik, Petra, Bartek, Jiri

    Published in Neuro-oncology (Charlottesville, Va.) (01-11-2014)
    “…Glioblastoma Multiforme (GBM) is among the most lethal of solid cancers in adults. GBM is associated with a median survival of only approximately 15 months…”
    Get full text
    Journal Article
  15. 15

    CB-05 THE ROLE OF Emb-5 IN GLIOBLASTOMA MAINTENANCE AND THERAPEUTIC RESISTANCE by Rasmussen, R. D., Jensen, K. E., Gajjar, M. K., Julie la Cour Karottki, K., Bartek, J., Skjoth-Rasmussen, J., Tluckova, L., Hamerlik, P.

    Published in Neuro-oncology (Charlottesville, Va.) (01-11-2014)
    “…Glioblastoma Multiforme (GBM) is among the most lethal of solid cancers in adults. GBM is associated with a median survival of only approximately 15 months…”
    Get full text
    Journal Article